The Complex Interplay between Metabolic Reprogramming and Epigenetic Alterations in Renal Cell Carcinoma

Area of Science:

• Oncology
• Cancer Biology
• Metabolism

Background:

• Renal cell carcinoma (RCC) is the most common kidney cancer.
• Current therapies for localized RCC are effective but do not prevent recurrence or metastasis.
• New therapeutic strategies targeting RCC biology are crucial.

Purpose of the Study:

• To review the biological properties of RCC, focusing on metabolic reprogramming and epigenetic alterations.
• To highlight the interplay between genetic/epigenetic changes and metabolic deregulation in RCC.
• To discuss the clinical relevance of targeting metabolic-epigenetic interactions in RCC.

Main Methods:

• Literature review of current research on RCC biology.
• Analysis of genetic and epigenetic alterations contributing to metabolic deregulation.
• Discussion of epigenetic enzyme regulation by metabolite accumulation.

Main Results:

• RCC cells exhibit metabolic reprogramming, including the Warburg effect (high glycolysis).
• Aberrant metabolite accumulation influences epigenetic enzyme regulation in RCC.
• These interactions play a role in RCC emergence and progression.

Conclusions:

• Uncovering novel therapeutic targets based on metabolic and epigenetic reprogramming is clinically relevant.
• Targeting these pathways can potentially improve treatment and survival for RCC patients.
• Further research into the metabolic-epigenetic crosstalk in RCC is warranted.